In a recent transaction, Shubham Maheshwari, the Chief Financial Officer of Varex Imaging Corp (NASDAQ:VREX), purchased shares of the company's common stock, signaling a vote of confidence in the firm's prospects. On August 12, 2024, Maheshwari acquired 10,000 shares at a weighted average price between $10.82 and $10.83 per share, with a total investment of $108,200.
The purchase of Varex Imaging shares by the CFO comes as a notable financial move, increasing his total ownership to 56,063 shares directly held after the transaction. The price range for the shares was narrowly defined, indicating a consistent market value during the time of purchase.
Investors often monitor insider transactions such as these for insights into the perspectives of high-ranking officials within a company. The actions of executives can reflect their personal outlook on the company's valuation and future performance.
Varex Imaging Corp, headquartered in Salt Lake City, Utah, operates within the electronic components sector, providing specialized products and services. The company's stock is publicly traded and can be followed for performance updates and further insider transactions.
In other recent news, Varex Imaging Corporation reported mixed financial results for the third quarter of fiscal year 2024. The company experienced a 10% decline in revenue year-over-year, with the Medical segment seeing a significant 15% decrease. However, the Industrial segment reported a 6% increase in revenue. Varex ended the quarter with a strong cash position of $192 million. The company's outlook for the fourth quarter projects revenue between $190 million and $210 million, with non-GAAP EPS of $0.00 to $0.15. Varex also anticipates challenges in the Chinese market and increased competition from Asia-based manufacturers. Despite these challenges, the company is optimistic about a gradual improvement in fiscal year 2025, with progress being made with new photon counting technology products and cost-cutting initiatives in India. These are recent developments in the company's operations.
InvestingPro Insights
In light of the CFO's recent stock purchase, it's worth examining Varex Imaging Corp's financial health and market performance with insights from InvestingPro. Despite the signal of confidence from Shubham Maheshwari, InvestingPro Tips suggest a mixed financial forecast for the company. Analysts have revised their earnings expectations downwards for the upcoming period, which could indicate potential headwinds for profitability. Additionally, while the company is trading at a high P/E ratio relative to near-term earnings growth, suggesting a premium on its current earnings, the valuation also implies a strong free cash flow yield, which could be a positive sign for investors looking for cash-generating investments.
From a market performance perspective, Varex's stock has struggled over the last month with a significant price decline. However, the company has been profitable over the last twelve months, and analysts predict it will remain profitable this year. This could provide some reassurance to investors concerned about the recent stock price performance.
The InvestingPro Data metrics offer further insights into the company's valuation and performance. Varex Imaging Corp has a market capitalization of $473.99 million and a P/E ratio of 13.73, which adjusts to 10.7 for the last twelve months as of Q3 2024. The company's revenue has seen a decline of 7.21% over the last twelve months, which could be a contributing factor to the stock's recent performance. However, the company's gross profit margin remains solid at 32.16%, reflecting its ability to maintain profitability despite revenue headwinds.
For investors seeking additional information, there are more InvestingPro Tips available at https://www.investing.com/pro/VREX, which could provide further guidance on the company's financial outlook and investment potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.